Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
Biorxiv : the Preprint Server for Biology
|
May 4, 2026
Macrocyclization of Broad-Spectrum Kinase Inhibitor Bosutinib leads to Potent and Selective Quinoline-based HIPK4 Inhibitor AZ137
Athina Zerva, Nicolai D Raig, Zaile Zhuang, et al.
Journal of Medicinal Chemistry
|
December 21, 2023
Synthesis of Pyrazole-Based Macrocycles Leads to a Highly Selective Inhibitor for MST3
Jennifer Alisa Amrhein, Lena Marie Berger, Dimitrios-Ilias Balourdas, et al.
Science Advances
|
June 4, 2025
Type II kinase inhibitors that target Parkinson's disease-associated LRRK2
Nicolai D Raig, Katherine J Surridge, Marta Sanz-Murillo, et al.
European Journal of Medicinal Chemistry
|
April 24, 2023
Shifting the selectivity of pyrido[2,3-d]pyrimidin-7(8H)-one inhibitors towards the salt-inducible kinase (SIK) subfamily
Marcel Rak, Roberta Tesch, Lena M Berger, et al.
Journal of Medicinal Chemistry
|
July 19, 2024
Back-Pocket Optimization of 2-Aminopyrimidine-Based Macrocycles Leads to Potent EPHA2/GAK Kinase Inhibitors
Joshua Gerninghaus, Rezart Zhubi, Andreas Krämer, et al.
Biorxiv : the Preprint Server for Biology
|
February 26, 2024
Back-pocket optimization of 2-aminopyrimidine-based macrocycles leads to potent dual EPHA2/GAK kinase inhibitors with antiviral activity
Joshua Gerninghaus, Rezart Zhubi, Andreas Krämer, et al.
Journal of Medicinal Chemistry
|
February 29, 2024
Development of Selective Pyrido[2,3-<i>d</i>]pyrimidin-7(8<i>H</i>)-one-Based Mammalian STE20-Like (MST3/4) Kinase Inhibitors
Marcel Rak, Amelie Menge, Roberta Tesch, et al.
ACS Medicinal Chemistry Letters
|
November 19, 2025
Un-LOK-ing a New Approach for Conformational Selective Targeting of STK10 (LOK)
Martina Dettenhöfer, Laura Nadine Tandara, Jennifer Alisa Amrhein, et al.
ACS Chemical Biology
|
April 14, 2025
Repurposing of the RIPK1-Selective Benzo[1,4]oxazepin-4-one Scaffold for the Development of a Type III LIMK1/2 Inhibitor
Sebastian Mandel, Thomas Hanke, Sebastian Mathea, et al.
Journal of Medicinal Chemistry
|
June 17, 2026
On the Scope of DCAF1-Recruiting PROTACs Degrading Protein Kinases
Janik Weckesser, Nebojša Miletić, Saran Aswathaman Sivashanmugam, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
Biorxiv : the Preprint Server for Biology
|
May 4, 2026
Macrocyclization of Broad-Spectrum Kinase Inhibitor Bosutinib leads to Potent and Selective Quinoline-based HIPK4 Inhibitor AZ137
Athina Zerva, Nicolai D Raig, Zaile Zhuang, et al.
Journal of Medicinal Chemistry
|
December 21, 2023
Synthesis of Pyrazole-Based Macrocycles Leads to a Highly Selective Inhibitor for MST3
Jennifer Alisa Amrhein, Lena Marie Berger, Dimitrios-Ilias Balourdas, et al.
Science Advances
|
June 4, 2025
Type II kinase inhibitors that target Parkinson's disease-associated LRRK2
Nicolai D Raig, Katherine J Surridge, Marta Sanz-Murillo, et al.
European Journal of Medicinal Chemistry
|
April 24, 2023
Shifting the selectivity of pyrido[2,3-d]pyrimidin-7(8H)-one inhibitors towards the salt-inducible kinase (SIK) subfamily
Marcel Rak, Roberta Tesch, Lena M Berger, et al.
Journal of Medicinal Chemistry
|
July 19, 2024
Back-Pocket Optimization of 2-Aminopyrimidine-Based Macrocycles Leads to Potent EPHA2/GAK Kinase Inhibitors
Joshua Gerninghaus, Rezart Zhubi, Andreas Krämer, et al.
Biorxiv : the Preprint Server for Biology
|
February 26, 2024
Back-pocket optimization of 2-aminopyrimidine-based macrocycles leads to potent dual EPHA2/GAK kinase inhibitors with antiviral activity
Joshua Gerninghaus, Rezart Zhubi, Andreas Krämer, et al.
Journal of Medicinal Chemistry
|
February 29, 2024
Development of Selective Pyrido[2,3-<i>d</i>]pyrimidin-7(8<i>H</i>)-one-Based Mammalian STE20-Like (MST3/4) Kinase Inhibitors
Marcel Rak, Amelie Menge, Roberta Tesch, et al.
ACS Medicinal Chemistry Letters
|
November 19, 2025
Un-LOK-ing a New Approach for Conformational Selective Targeting of STK10 (LOK)
Martina Dettenhöfer, Laura Nadine Tandara, Jennifer Alisa Amrhein, et al.
ACS Chemical Biology
|
April 14, 2025
Repurposing of the RIPK1-Selective Benzo[1,4]oxazepin-4-one Scaffold for the Development of a Type III LIMK1/2 Inhibitor
Sebastian Mandel, Thomas Hanke, Sebastian Mathea, et al.
Journal of Medicinal Chemistry
|
June 17, 2026
On the Scope of DCAF1-Recruiting PROTACs Degrading Protein Kinases
Janik Weckesser, Nebojša Miletić, Saran Aswathaman Sivashanmugam, et al.
Page
of 3